And, while purchasing and consumption of snacks, processed foods and sugary drinks is down among those using GLP-1 medications, the study found patients still have a desire for them
Cardioprotective Research A significant body of preclinical research suggests GHRP-6 has cardioprotective and cytoprotective properties beyond its GH-releasing activity
The study included a survey with 1,955 useable observations including 495 people who were currently taking a GLP-1, 468 who had previously taken one, 492 people who were planning to take one, and 500 people who were neither taking one nor planning to take one
Lifestyle change remains the foundation for all weight loss GLP-1 agonists like Wegovy, Saxenda, and Zepbound are designed to be used for the chronic treatment of obesity, not something to be used in the short-term
Compounded tirzepatide from Lavender Sky may use slightly different escalation schedules depending on vial concentrations and tier structures
This synthetic peptide, derived from a natural protein in the stomach, has been studied for its potential in tissue repair, inflammation control, and cell protection